IRON
Price
$54.50
Change
+$0.37 (+0.68%)
Updated
Jun 27 closing price
Capitalization
1.89B
41 days until earnings call
PRTC
Price
$17.15
Change
-$0.79 (-4.40%)
Updated
Jun 27 closing price
Capitalization
422.23M
60 days until earnings call
Interact to see
Advertisement

IRON vs PRTC

Header iconIRON vs PRTC Comparison
Open Charts IRON vs PRTCBanner chart's image
Disc Medicine
Price$54.50
Change+$0.37 (+0.68%)
Volume$1.06M
Capitalization1.89B
PureTech Health
Price$17.15
Change-$0.79 (-4.40%)
Volume$40.18K
Capitalization422.23M
IRON vs PRTC Comparison Chart in %
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. PRTC commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a StrongBuy and PRTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (IRON: $54.53 vs. PRTC: $17.48)
Brand notoriety: IRON and PRTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 203% vs. PRTC: 886%
Market capitalization -- IRON: $1.89B vs. PRTC: $422.23M
IRON [@Biotechnology] is valued at $1.89B. PRTC’s [@Biotechnology] market capitalization is $422.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whilePRTC’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • PRTC’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than PRTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 6 TA indicator(s) are bullish.

  • IRON’s TA Score: 6 bullish, 4 bearish.

Price Growth

IRON (@Biotechnology) experienced а +5.67% price change this week, while PRTC (@Biotechnology) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

IRON is expected to report earnings on Aug 08, 2025.

PRTC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($1.89B) has a higher market cap than PRTC($422M). PRTC YTD gains are higher at: -5.309 vs. IRON (-13.983). PRTC has higher annual earnings (EBITDA): -53.65M vs. IRON (-114.41M). IRON has more cash in the bank: 695M vs. PRTC (502M). PRTC has less debt than IRON: PRTC (24M) vs IRON (30.6M). IRON (0) and PRTC (0) have equivalent revenues.
IRONPRTCIRON / PRTC
Capitalization1.89B422M448%
EBITDA-114.41M-53.65M213%
Gain YTD-13.983-5.309263%
P/E RatioN/A8.32-
Revenue00-
Total Cash695M502M138%
Total Debt30.6M24M128%
TECHNICAL ANALYSIS
Technical Analysis
IRON
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNWFX87.390.19
+0.22%
American Funds New World 529F
RPFFX10.43N/A
N/A
Royce Premier Service
MGGLX36.70N/A
N/A
Morgan Stanley Inst Global Opp L
MRASX11.26N/A
N/A
Cromwell CenterSquare Real Estate Inst
TGWRX14.06N/A
N/A
Transamerica Large Growth R

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with KMSTF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.75%
KMSTF - IRON
54%
Loosely correlated
N/A
CGON - IRON
50%
Loosely correlated
-0.46%
IDYA - IRON
49%
Loosely correlated
-4.04%
SYRE - IRON
48%
Loosely correlated
-4.99%
ZYME - IRON
47%
Loosely correlated
+0.73%
More

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and ZLAB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and ZLAB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
-2.56%
ZLAB - PRTC
31%
Poorly correlated
-3.87%
AUTL - PRTC
31%
Poorly correlated
+0.43%
RLMD - PRTC
31%
Poorly correlated
-9.37%
IRON - PRTC
30%
Poorly correlated
+0.75%
PTCHF - PRTC
29%
Poorly correlated
N/A
More